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Abstract 
 
The relationship between obesity and heart rate variability (HRV) has been 
studied in adults and adolescents, but is not determined in young pediatrics.  The purpose 
of this study was to assess autonomic activity using HRV in a pediatric population.  We 
hypothesized that obese children would have reduced parasympathetic and increased 
sympathetic activity compared to age-matched subjects. 42 pediatric subjects (ages 3-5) 
were classified into 3 groups based on body mass index-for-age; normal, overweight and 
obese.  HRV and respiratory rate were recorded during 3 minute baseline, 2 minute 
isometric handgrip and 3 minute recovery.  HRV was analyzed in the time domain [heart 
rate (HR), RR interval (RRI) and RRI standard deviation (RRISD)] and frequency 
domain [low frequency (LF), high frequency (HF) and LF/HF ratio] using repeated 
measures ANOVA.  Spearman’s correlations were used to examine the relations between 
BMI and HRV at rest.  Significant condition effects were found between baseline, 
exercise and recovery, but these responses were not significantly different between the 
normal, overweight and obese children.  BMI was negatively correlated with LF/HF, 
while BMI was positively correlated with RRISD, LF, HF and nHF. Our data 
demonstrate that higher BMI in the pediatric population is correlated with higher 
parasympathetic and lower sympathetic activity.  These findings are contrary to HRV 
responses observed in adults and adolescents, suggesting complex relationships between 
age, obesity and autonomic control of the heart. The data supports the concept of an age 
reliance of HRV and a novel relationship between adiposity and body mass index in 3-5 
year olds. 
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  Effects of Pediatric Adiposity on Heart Rate Variability 
 
 
INTRODUCTION 
Heart rate variability (HRV) provides a noninvasive index of the neural activity of 
the heart and is commonly used to examine the autonomic nervous system.  Time domain 
analysis and frequency domain analysis are the two main HRV analytical approaches.  
The power spectrum of HRV characterizes the frequency domain properties of heart beat 
variation by applying spectrum assessment techniques to R-R interval data measured by 
an electrocardiogram.  This analysis produces frequency components including high 
frequency (HF) which reflects mainly parasympathetic activity and low frequency (LF) 
which reflects both parasympathetic and sympathetic activity.  HRV is considered a 
reliable, noninvasive technique for assessing neural control of the cardiovascular system 
(Pagani and Malliani 2000).  
The incidence of obesity is rapidly rising to epic proportions, especially in 
younger populations.  According to the 2003-2004 National Health and Nutrition 
Examination Survey, 17% of children and adolescents ages 2-19 years are overweight 
(Ogden et al. 2006).  Previous researchers have shown that overweight children have a 
much greater chance of becoming overweight or obese adults (Kotani et al. 1997 and 
Whitaker et al. 1997). Obesity has been shown to increase the risk of many diseases, 
including diabetes, cardiovascular disease, osteoarthritis, urinary incontinence, 
gallbladder disease, sleep disorders, cancer, psychological problems and mental disorders 
(Kotani et al. 1997 and Yakinci et al. 2000).  Previous studies in obese adolescents show 
an association with increased morbidity (Folsom et al. 1996 and Liu et al. 1996) and 
mortality rates (Evrengul et al. 2006 and Finley et al. 1995).  Obesity is also characterized 
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by autonomic nervous system dysfunction.  Low HRV, which represents a greater 
prevalence of sympathetic tone, has been associated with a high cardiovascular risk 
(Kleiger et al. 1987).    
Body Mass Index (BMI) is a common method utilized to screen for obesity in 
children due to its ease of measurement and reliability.  Although BMI does not directly 
measure body fat, it is a reliable indicator of adiposity for most children.  Studies have 
shown that BMI correlates to underwater weighing and dual energy x-ray absorptiometry 
(Mei et al. 2002).  BMI for children is calculated on a separate scale than adults and is 
referred to as BMI-for-age.   Percentile rankings are established based on The Centers for 
Disease Control and Prevention BMI-for-age growth charts based on sex.  Percentile 
ranges are as follows: 1) underweight is less than the 5th percentile, 2) healthy weight 
includes the 5th percentile to less than the 85th percentile, 3) at risk of overweight includes 
the 85th to less than the 95th percentile, and 4) overweight is equal to or greater than the 
95th percentile.  The American Medical Association recommends classifying children 
with BMI’s greater than the 95th percentile for age and sex as obese and those with BMI’s 
greater than the 85th but less than the 95th percentile as overweight (Goutham 2008).  For 
the purpose of this thesis, we will classify our subjects based on Goutham (2008). 
HRV has been used in several studies with infants and children because it is easily 
applicable and noninvasive.  Although many studies have utilized HRV with infants and 
children, few have specifically examined the relationship between HRV and childhood 
obesity.  In those that have, it appears that obesity does influence HRV in obese children 
(Martini et al. 2001; Nagai et al. 2003; Rabbia et al. 2003; Riva et al. 2001; Yakinci et al. 
2000).  Previous studies have focused primarily on the adolescent population and the link 
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between reduced HRV and obesity. Specifically, HRV studies suggest increased obesity 
is associated with a reduction in parasympathetic activity (Martini et al. 2001; Nagai et al. 
2003; Rabbia et al. 2003; Riva et al. 2001 and Yakinci et al. 2000) and either an increase 
(Martini et al. 2001; Rabbia et al. 2003 and Riva et al. 2001), decrease (Nagai et al. 2003) 
or no change (Yakinci et al. 2000) in sympathetic activity.  Since reduced HRV has been 
found to be a significant predictor of cardiac mortality and morbidity, the altered HRV 
response to obesity is of great importance to the pediatric population. To date, no studies 
have examined the relationship between HRV and obesity in the young pediatric 
population, specifically 3 to 5 year olds. 
The purpose of this study was to determine whether the autonomic nervous 
system, specifically sympathetic and parasympathetic activity assessed via HRV, is 
reduced in a pediatric obese population.  Based on HRV studies performed in adults and 
adolescents, we hypothesized that obese children will have reduced parasympathetic 
activity.  Examining this relationship in the younger population will provide new insights 
into the effects of early obesity on the autonomic nervous system.      
 
METHODS 
 Subjects.  Forty two children (age 4.0 ± 0.1 years) were recruited from a local 
preschool program (BHK Child Development, Houghton, MI) to participate in this study. 
Three experimental groups were studied based on BMI-for-age: 1) normal weight (9 
males, 5 females), 2) overweight (9 males, 5 females), and 3) obese (2 males, 12 
females).  Subject baseline characteristics are outlined in Table 1.  All subjects abstained 
from exercise and caffeine for ≥ 12 h before laboratory testing. The Michigan 
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Technological University Human Subjects Research Committee granted approval for 
testing.  All children and their parents were instructed on the study and provided 
informed assent and consent to participate. 
 
Table 1. Baseline characteristics of normal weight, overweight and obese children. 
Variable Normal Overweight Obese 
HT (cm) 103 ± 1 106 ± 1 111 ± 3* 
WT (kg) 17 ± 0 20 ± 1* 24 ± 1*† 
BMI (kg/m²) 16 ± 0 18 ± 0* 19 ± 0*† 
SAP (mmHg) 88 ± 3 87 ± 3 92 ± 2 
DAP (mmHg) 59 ± 1 59 ± 1 59 ± 1 
MAP (mmHg) 69 ± 2 68 ± 2 69 ± 2 
MVC (p.s.i.) 2 ± 0 2 ± 0 2 ± 0 
 
* Significantly different from normal, † significantly different from overweight, p < 0.05. 
HT, height (cm); WT, weight (kg); BMI, body mass index (kg/m²); SAP, systolic arterial 
blood pressure (mmHg); DAP, diastolic arterial blood pressure (mmHg); MAP, mean 
arterial blood pressure (mmHg); MVC, maximal voluntary contraction (p.s.i.). 
 
Study design.  Participants were prepared for electrode placement for 
measurement of heart rate via a 3-lead electrocardiogram.  Resting arterial blood pressure 
was obtained using sphygmomanometer after the subject had been sitting quietly for 5 
minutes. Three measurements were taken and the average was reported for resting arterial 
blood pressure. Subjects were then asked to grip a pediatric bulb dynamometer to obtain 
a maximal voluntary contraction (MVC).   An average MCVC was determined from 3 
recordings.  A colorful sticker was placed on the dynamometer to illustrate 30% MVC.  
Subjects then demonstrated they could perform the task by maintaining 30% MVC.  
Subjects were positioned supine on a table for five minutes to obtain a resting 
measurement.  Following a 3 minute baseline, subjects performed isometric handgrip at 
30% of their MVC for 2 minutes.  A 3 minute recovery was recorded after the isometric 
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handgrip.  All subjects watched the movie “Stuart Little” during the baseline and 
recovery stages.   
 Heart rate variability analyses.  An electrocardiogram (ECG) detects electrical 
activity occurring in the heart through electrodes placed on the skin.   An ECG is used as 
a means of measuring electrical potential with impulses appearing as a series of positive 
and negative deflections. Cardiac events are correlated to the ECG and produce distinct 
waves.  Specifically, the SA node depolarizes to produce a P wave followed by 
depolarization of the ventricles which brings about ventricular contraction and the QRS 
complex. The T wave is produced from ventricular repolarization.  Figure 1 depicts a 
representative tracing of an ECG from the current study. 
Heart rate variability (HRV) refers to the beat to beat variations in heart rate and 
can be measured using an ECG.  The ECG exhibits periodic variation in R-R intervals 
which can be associated with the phase of respiration. The analysis of HRV offers a non-
invasive method of evaluating vagal input into cardiac rhythm and only requires ECG 
equipment, microprocessors and relevant software for carrying out Fourier analyses.  
There are 2 major components of HRV.  High frequency is synchronous with respiration 
and reflects parasympathetic activity.  Low frequency is mediated by both the vagus and 
cardiac sympathetic nerves and reflects both sympathetic and parasympathetic activity.   
HRV can be measured using time or frequency domain analysis. Time domain is 
measured manually from an ECG by calculating the mean R-R interval and its standard 
deviation.  Small standard deviations in R-R intervals represented low HRV.  Nearly 30 
different types of arithmetic manipulations of R-R intervals in the time domain exist 
today, all seeming to be largely equal with no one superior method.  Time domain is 
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easily performed using the heart rate at any point in time or the intervals between 
successive normal complexes.     
 HRV can also be expressed in the frequency domain as the sum of oscillations 
based on their frequency and amplitudes. The frequency domain is represented by the 
sum of sinusoidal components of different amplitude, frequency and phase values. More 
specifically, the R-R signal is transformed from time to frequency domain by 
representing the signal as a combination of sine and cosine waves, with different 
amplitudes and frequencies. The oscillatory components are evaluated using many 
different algorithms (Task Force on HRV 1996), including the fast Fourier transform 
(FFT).  The FFT is frequently used since it is easier to implement than many of the other 
methods.   
Fast Fourier Transform converts the R-R interval time domain into sine and 
cosine waves, with the goal of ending up with something easier to deal with than the 
original signal. The frequency of each sinusoid is fixed and only the amplitude is changed 
depending on the shape of the waveform being decomposed.  The frequency domain 
contains similar information as the time domain, just in a different form. This thesis will 
report the effects of pediatric adiposity on heart rate variability expressed in both the time 
domain and frequency domain.  Both are well established techniques that provide insight 
into autonomic neural control of the heart.  
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Figure 1. Representative tracings of electrocardiogram (ECG),  
RR interval (RRI) and power spectral density (PSD) during  
baseline in one subject. 
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Measurements.  Height and weight were measured on each subject.  Body mass 
index was calculated from each subject’s weight and height by plotting on the BMI-for-
age growth chart dependent on sex to obtain a percentile ranking.  Resting blood pressure 
was measured with a manual sphygmomanometer. A three-lead electrocardiogram was 
used to record continuous heart rate.  Respiratory rate was measured using a 
pneumograph.   Data from the electrocardiogram was sampled at 500 Hz and stored on a 
computer (WINDAQ, Dataq Instruments, Akron, OH).  A pediatric bulb dynamometer 
was used for the isometric handgrip.  
Data analysis.  Data were imported into a software program for data analysis 
(WinCPRS, Absolute Aliens Ay, Turku, Finland).  R-waves were detected and marked in 
the time series.  Data were analyzed by using SPSS statistical software (SPSS, version 
15.0, Chicago, IL).  Analyses of HRV variables between groups were performed using 
repeated measures analysis of variance.  The least-significant difference pairwise 
comparison method was used for post-hoc analyses.  The relationship between BMI and 
HRV variables was examined by Spearman correlation analysis. Significant differences 
were determined when p < 0.05.  All results are presented as means ± standard errors. 
 
RESULTS 
Table 2 displays HRV variables for normal, overweight and obese children.  
There were significant differences during baseline, exercise and recovery for all 9 HRV 
variables (condition effect, p < 0.05).  Figures 2 and 3 demonstrate that there was a 
significant difference between baseline and exercise for HR, RRI, LF/HF, nLF, nHF and 
respiration.  Figures 2 and 3 also demonstrate that there was a significant difference 
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between baseline and recovery for RRISD, LF, nLF and respiration.  The HRV 
responses were not significantly different between the normal, overweight and obese 
children (condition x group effect, p > 0.05).  Therefore, adiposity did not have an effect 
on HRV.  
 
Table 2. Difference in HRV parameters of normal weight, overweight and obese 
children. 
Variable Group N Mean Base Mean Exercise Mean Recovery 
HR (bpm) Normal 13 102 ± 3 109 ± 3 102 ± 2 
 Overweight 14 98 ± 3 104 ± 3 98 ± 3 
 Obese 14 93 ± 2 102 ± 2 93 ± 2 
RRI (ms) Normal 13 599 ± 17 559 ± 17 597 ± 16 
 Overweight 14 630 ± 22 588 ± 21 629 ± 20 
 Obese 14 661 ± 17 602 ± 14 656 ± 18 
RRISD (ms) Normal 13 41 ± 8 39 ± 7 46 ± 7 
 Overweight 14 64 ± 13 59 ± 10 70 ± 11 
 Obese 14 65 ± 7 53 ± 5 72 ± 7 
LF (ms²) Normal 13 378 ± 85 324 ± 85 588 ± 133 
 Overweight 14 723 ± 229 947 ± 244 1140 ± 336 
 Obese 14 961 ± 154 751 ± 120 1667 ± 497 
HF (ms²) Normal 13 575 ± 290 539 ± 387 713 ± 352 
 Overweight 14 2198 ± 1025 1085 ± 496 2136 ± 820 
 Obese 14 1599 ± 364 874 ± 309 1977 ± 484 
LF/HF  Normal 13 182 ± 29 215 ± 42 246 ± 59 
 Overweight 14 138 ± 39 237 ± 49 188 ± 54 
 Obese 14 93 ± 18 172 ± 33 113 ± 17 
nLF (nu) Normal 13 0.53 ± 0.05 0.56 ± 0.06 0.57 ± 0.05 
 Overweight 14 0.41 ± 0.06 0.57 ± 0.05 0.48 ± 0.06 
 Obese 14 0.41 ± 0.04 0.52 ± 0.06 0.46 ± 0.04 
nHF (nu) Normal 13 0.35 ± 0.04 0.36 ± 0.17 0.34 ± 0.05 
 Overweight 14 0.46 ± 0.05 0.34 ± 0.04 0.41 ± 0.05 
 Obese 14 0.50 ± 0.03 0.40 ± 0.05 0.47 ± 0.04 
Resp (breaths/min) Normal 13 26 ± 1 28 ± 1 25 ± 1 
 Overweight 14 25 ± 1 28 ± 2 24 ± 1 
 Obese 14 24 ± 1 28 ± 1 23 ± 1 
 
HR, heart rate (bpm); RRI, RR intervals (ms); RRISD, RR interval standard deviation (ms);  
LF, low frequency (ms²); HF, high frequency (ms²); LF/HF, low to high frequency ratio (ms²); nLF,  
normalized low frequency (nu); nHF, normalized high frequency (nu); Resp, Respiration breaths per 
 minute.  No group x condition effects were found.  Condition effects are shown in Figures 1.1 and 1.2.  
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Figure 2. Heart rate (HR), RR interval (RRI) and RRI standard deviation (RRISD) 
during baseline, exercise and recovery for normal, overweight and obese children.  
 HR and RRI were significantly different from baseline during exercise.  RRISD was 
significantly different from baseline during recovery. * Significantly different from 
baseline (p<0.05). 
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Figure 3. Low frequency (LF), high frequency (HF), LF/HF, normalized LF (nLF), 
 normalized HF (nHF) and Respiration during baseline, exercise and recovery for normal, 
overweight and obese children. LF/HF, nLF, nHF and respiration were significantly different from 
baseline during exercise.  LF, nLF and respiration were significantly different from baseline 
during recovery. * Significantly different from baseline (p<0.05). 
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Figure 4 demonstrates that BMI was significantly correlated to LF, HF and 
LF/HF. Figure 5 shows that BMI was not correlated to HR and MAP.  
 
Figure 4. Relations between BMI (kg/m²) and HF, LF and LF/HF during baseline.  
 
 
Figure 5. Relations between BMI (kg/m²) and heart rate (HR)  
             and mean arterial pressure (MAP) during baseline. 
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DISCUSSION 
This study is the first to report the influence of adiposity on HRV in a pediatric 
population of 3-5 year olds.  Primary findings indicate significant differences in HRV 
during exercise, but no differences were found between normal, overweight and obese 
children.  Contrary to our original hypothesis, higher BMI in the pediatric population was 
associated with higher parasympathetic and lower sympathetic activity.  These findings 
are contrary to HRV responses observed in adults and adolescents, which suggests 
complex relationships between age, obesity and autonomic control of the heart. 
Although differences in HRV variables were not found between normal, 
overweight and obese children, significant condition effects were observed.  Specifically, 
HR, LF/HF and nLF increased during exercise while RRI, nHF and respiration decreased.  
RRISD, LF and HF were not altered during exercise.  Studies have examined the pattern 
of HRV variables during exercise, but never in children ages 3-5 years old.  Chen et al. 
(2007) looked at HRV variables in children (ages 8-13 years) with Type I diabetes during 
10 minutes of exercise on a fixed rhythm stair-stepper.  Both LF and HF significantly 
decreased during exercise, demonstrating a reduction in both sympathetic and 
parasympathetic activity. A normal cardiovascular response to exercise in healthy 
subjects is parasympathetic withdrawal, which results in increased HR and greatly 
reduced HRV (Yoshiharu et al. 1991 and Macor et al. 1996).  This exercise response was 
observed in all 3 groups of the current study, including the overweight and obese groups.  
The reduction in parasympathetic activity, determined by HF, tended to decrease during 
exercise in all groups, but did not quite reach statistical significance (p < 0.09).  
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Therefore, our exercise findings confirm previous work of Chen et al. (2007), that 
parasympathetic activity decreases during exercise.  
 Previous studies on children ages 6 to 14 years old have reported increased 
adiposity in children is associated with reduced HRV (Martini et al. 2001; Nagai et al. 
2003; Rabbia et al. 2003; Riva et al. 2001 and Yakinci et al. 2000).  Increased levels of 
adiposity were associated with decreased parasympathetic activity and either an increase 
(Martini et al. 2001; Rabbia et al. 2003 and Riva et al. 2001), decrease (Nagai et al. 2003) 
or no change (Yakinci et al. 2000) in sympathetic activity.  To date, no studies have 
examined the influence of adiposity on HRV in young pediatric patients.  The current 
study demonstrated no change in HRV between normal, overweight and obese 3-5 year 
olds.  In fact, higher BMI was associated with higher parasympathetic and lower 
sympathetic activity.  This is in stark contrast to what has been observed in previous 
studies, which is lower parasympathetic activity and variable sympathetic responses to 
obesity.     
Reduced sympathetic activity in obese children has been previously reported by 
Nagai et al. (2004).  Reductions of sympathetic activity have been shown to lead to lower 
energy expenditure levels, and consequently, a positive energy balance and weight gain 
(Peterson et a. 1988).  However, lower sympathetic activity induced by obesity is not a 
consistent finding, as Martini et al. (2001); Rabbia et al. (2003) and Riva et al. (2001) 
have reported increased sympathetic activity with obesity.  Controversial findings 
regarding sympathetic activity are also present in adult obesity.  Bray et al. (1986) and 
Matsumoto et al. (1999) reported decreased sympathetic activity and associated it with 
the duration of obesity, leading to the conclusion that reduced sympathetic activity leads 
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to the onset or development of obesity.  Discrepancies may result from the use of 
different methods in analyzing the autonomic nervous system.  Thus, the role of adiposity 
on sympathetic activity remains controversial.  Potential explanations for this controversy 
may be due to difficulty controlling for variables such as age, gender, duration of obesity, 
medical complications, nutrition, activity habits and emotional stress.   
Whereas the influence of adiposity on sympathetic activity remains controversial, 
parasympathetic responses to obesity are remarkably consistent.  All previous literature 
on parasympathetic activity and obese children aged 6 years and older demonstrate 
reduced parasympathetic activity (Martini et al. 2001; Nagai et al. 2003; Rabbia et al. 
2003; Riva et al. 2001 and Yakinci et al. 2000). Specifically, Nagai et al. (2003) reported 
significantly decreased HF in obese children during 5 minute recordings.  Martini et al. 
(2001); Rabbia et al. (2003); and Riva et al. (2001) observed significantly reduced HF 
using 24 hour Holter monitors.  Furthermore, Yakinci et al. (2000) observed decreased 
HF measured via Valsalva’s maneuver.  Thus, evidence suggests increased adiposity is 
associated with decreased parasympathetic activity in children and adolescents.   
In the current study, power spectral analyses detected several correlations 
between BMI and HRV variables.  RRISD, LF, HF and nHF were all positively 
correlated with BMI while LF/HF was negatively correlated with BMI.  The increase of 
HF with increasing levels of BMI suggest an increase in parasympathetic activity as one 
because obese.  Thus, in contrast to previous studies (Martini et al. 2001; Nagai et al. 
2003; Rabbia et al. 2003; Riva et al. 2001 and Yakinci et al. 2000), the current study 
demonstrated higher adiposity in children ages 3-5 years old was associated with higher 
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parasympathetic activity.  The differences between our study and others are likely due 
to the influence of age on the developing heart. 
Massin et al. (1997) demonstrated that heart rate variability and mean RR 
intervals are dependant on age in normal subjects, and that both contribute to the 
differences in overall HRV.  More specifically, cholinergic increases and adrenergic 
decreases of HRV with age lead to the conclusion that the autonomic nervous system 
matures progressively.  Finley et al. (1995) further showed an age reliance of heart rate 
variability with LF and HF components increasing from one month to six years and 
decreasing there after until 24 years.  It was concluded that the changes in 
parasympathetic and sympathetic activity of heart rate during development are dependent 
upon age.  The greatest variability in the study by Finley et al. (1995) was found in the 
infant group, which was thought to be due to several mechanisms producing the heart rate 
variations, including development of the parasympathetic innervations of the sinoatrial 
node, changes in cardiac volume occurring with growth and respiratory factors affecting 
HF and LF variability.  Other studies have found that the maturation state in children 
affects autonomic nervous activity with greater vagal tone than adults (Lenard et al. 2004 
and Silvetti et al. 2001).  It is believed that both mechanical and neural alterations with 
age account for these differences (Lenard et al. 2004). The data presented in this thesis 
supports a novel relation between adiposity and BMI in 3-5 year olds.  The tight age 
range of our subjects (3-5 years old) and the variability associated with HRV did not 
allow us to probe more closely for the influence of age on our data.  Future studies should 
be conducted to further observe the combined influence of age and adiposity on HRV.   
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Increased physical activity is associated with higher levels of parasympathetic 
and sympathetic activity in adults (Davy et al. 1998; Goldsmith et al. 1992; and Amano et 
al. 2001) and children (Gutin et al. 2000). Physical activity levels were not considered or 
recorded for the subject’s who participated in this study.  One possible explanation for 
the increased parasympathetic activity in the obese children is that they were potentially 
more physically active than the normal and overweight subjects, although this does not 
agree with the assumptions that leaner children are naturally more active than their 
overweight and obese counterparts.  Another possibility is that with short onset of 
obesity, as with a pediatric population, the autonomic nervous system has yet to adapt 
fully to the alterations imposed by obesity. 
Autonomic nervous system activity was measured via HRV for this study, which 
is a well accepted method in the research, but was only measured for a limited amount of 
time.  HRV was recorded for 3 minutes at baseline, 2 minutes during exercise and 3 
minutes at recovery.  A pilot study was conducted which included a 5 minute baseline, 
but it was found to be too long to keep a child’s focus in a resting position.  Several 
studies report HRV during short-term recordings between 2 and 5 minutes (Pomeranze et 
al. 1985; Pagani et al. 1986; Sandercock et al. 2005 and Kleiger et al. 1991).  
Additionally, Finley utilized 4 minute segments of continuous electrocardiogram 
recordings when examining HRV in subjects 5 to 24 years of age.  Therefore, we are 
confident that our 8 minute protocol was appropriate and valid. 
One conclusion that can be drawn from this study is that the relations between 
HRV and adiposity in 3-5 year olds may not correlate the same in adults and adolescents.  
HRV in adults has been reported to be highly reproducible in both short term (2-10 min) 
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and long-term (24 h) studies (Pagani et al. 1986; Amara et al. 1998; Schroeder et al. 
2004; Guijt et al. 2007 and Pitzalis et al. 1996).  In contrast, Leicht et al. (2008) 
compared HRV during light to moderate exercise after 8 weeks and reported moderate to 
poor reproducibility in children. HRV is a valuable and useful tool for analyzing the 
autonomic nervous system, but future studies need to confirm the reproducibility of HRV 
in children and adolescents.  
In addition to HRV, we also examined resting heart rate and mean arterial 
pressure in the 3 groups.  Our findings demonstrate no differences in resting HR and 
MAP between normal, overweight, and obese pediatric subjects. Furthermore, HR and 
MAP were not correlated with BMI.  Yakinci et al. (2000) found similar results, 
demonstrating no correlation between BMI and differences of systolic or diastolic blood 
pressure in obese 7-13 year olds.  In contrast, Riva et al. (2001) reported higher blood 
pressure and Nagai et al. (2003) reported significantly higher HR in obese children.  
Furthermore, Rabbia et al. (2003) and Martini et al. (2001) observed both higher 24-hour 
diastolic blood pressure and HR in obese children.  These discrepancies demonstrate the 
complex relationships between heart rate, blood pressure and the pediatric population. 
In summary, this study is the first to report the influence of adiposity on HRV in 
3-5 year olds.  Contrary to HRV responses in adolescents and adults, higher BMI in the 
pediatric population appears to be associated with higher parasympathetic and lower 
sympathetic activity.  These discrepancies suggest a high level of complexity between the 
autonomic nervous system, obesity and the pediatric population.   
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Appendix A-1: Raw Data for subject descriptive characteristics 
 
Normal 
  Age Height Weight BMI 
Subject # Sex (yrs) (cm) (kg) (kg/m2)
1 M 5 112 20.3 16.1 
2 F 4 101 13.7 13.5 
3 M 4 104 18.0 16.7 
4 M 3 101 16.8 16.5 
5 M 4 102 17.1 16.6 
6 M 3 104 15.1 14.1 
7 F 4 104 16.7 15.5 
8 F 4 105 16.9 15.5 
9 M 4 110 18.4 15.1 
10 M 4 102 16.5 15.9 
11 M 4 104 17.3 16.1 
12 F 3 96 15.0 16.2 
13 M 4 107 18.2 16.0 
14 F 5 96 14.9 16.1 
 
Overweight 
  Age Height Weight BMI 
Subject # Sex (yrs) (cm) (kg) (kg/m2)
      
15 M 4 107 19.3 16.9 
16 F 4 107 20.1 17.7 
17 M 3 107 20.4 17.7 
18 M 5 109 20.1 17.0 
19 M 3 100 17.3 17.1 
20 F 4 99 17.0 17.4 
21 F 4 106 19.2 17.2 
22 F 3 99 16.7 17.1 
23 M 4 109 20.2 17.0 
24 M 4 104 18.7 17.4 
25 M 4 111 21.9 17.8 
26 M 4 106 19.6 17.3 
27 F 4 110 20.9 17.4 
38 M 5 116 23.4 17.3 
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Obese 
  Age Height Weight BMI 
Subject 
# Sex (yrs) (cm) (kg) (kg/m2)
      
28 F 4 111 26.1 21.4 
29 F 4 111 23.4 19.0 
30 F 4 101 19.1 18.8 
31 F 3 95 16.4 18.3 
32 F 3 98 18.1 18.8 
33 M 4 112 22.7 18.1 
35 M 4 109 22.1 18.6 
36 F 4 103 20.6 19.6 
37 F 4 113 23.6 18.4 
39 F 5 129 31.1 18.7 
40 F 4 123 37.7 24.8 
41 F 5 112 23.0 18.2 
42 F 5 118 27.2 19.5 
43 F 5 114 24.0 18.6 
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Appendix A-2: Raw Data for SAP, DAP and MAP 
 
Normal 
Subject # 
SAP 
(mmHg) 
DAP 
(mmHg)
MAP 
(mmHg)
1 88.0 62.0 70.7 
2 98.6 60.6 73.3 
3 82.6 52.0 62.2 
4 92.6 61.3 71.7 
5 80.6 59.3 66.4 
6 82.6 50.0 60.9 
7 82.6 62.6 69.3 
8 71.3 58.0 62.4 
9 112.3 70.0 84.1 
10 98.0 50.6 66.4 
11 81.3 60.6 67.5 
12 83.3 61.3 68.6 
13 95.0 62.0 73.0 
14 88.6 56.6 67.3 
 
Overweight 
Subject # 
SAP 
(mmHg) 
DAP 
(mmHg)
MAP 
(mmHg)
15 93.3 54.6 67.5 
16 61.3 62.6 62.2 
17 108.0 66.6 80.4 
18 100.6 62.6 75.3 
19 83.3 51.3 62.0 
20 75.3 51.3 59.3 
21 80.0 58.0 65.3 
22 84.6 56.6 65.9 
23 80.0 52.6 61.7 
24 83.3 64.0 70.4 
25 101.3 61.3 74.6 
26 84.0 55.3 64.9 
27 90.0 62.6 71.7 
38 89.3 62.3 71.3 
 
 26
Obese 
Subject # 
SAP 
(mmHg) 
DAP 
(mmHg)
MAP 
(mmHg)
28 84.6 60.0 68.2 
29 93.3 50.6 64.8 
30 85.3 55.3 65.3 
31 80.6 50.6 60.6 
32 87.3 62.0 70.4 
33 100.6 60.6 73.9 
35 108.7 67.7 81.4 
36 98.3 60.6 73.2 
37 97.3 60.6 72.8 
39 94.6 66.6 75.9 
40 98.0 61.3 73.5 
41 85.6 55.3 65.4 
42 93.6 60.6 71.6 
43 82.0 51.3 61.5 
 
SAP, systolic arterial blood pressure (mmHg);  
DAP, diastolic arterial blood pressure (mmHg);  
MAP, mean arterial blood pressure (mmHg) 
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Appendix A-3: Raw Data for HR (bpm) during baseline, exercise and recovery 
 
Normal 
Subject Baseline Exercise Recovery
1 98.7 117.9 98.5 
2 119 128.6 119.3 
3 92.6 103.5 92.9 
4 109.6 108.2 109.6 
5 93.5 101 96.7 
6 104.3 117.2 105.3 
7 101.4 105.7 103 
8 102.1 119.3 101.6 
9 99.6 - 98.4 
10 103.9 109.4 107.7 
11 98 102.1 99.2 
12 113.1 112.9 110.8 
13 82.6 86.7 83.4 
14 101 103.1 97.8 
 
Overweight 
Subject Baseline Exercise Recovery
15 88.4 98 89.9 
16 102.2 119.1 99 
17 114.7 119.7 116.1 
18 113.9 115.5 112 
19 87.6 87.7 91 
20 114.1 122.5 113.8 
21 94.1 107.5 96.9 
22 105.3 113.8 106.2 
23 84.6 93.2 83.1 
24 94.4 100.2 93 
25 104.1 101 102.4 
26 99.7 97.3 95.1 
27 88 100.6 86.8 
38 77.6 86.3 82.6 
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Obese 
Subject Baseline Exercise Recovery
28 96.4 112.8 100.1 
29 80.8 93.1 81.6 
30 94 108.4 98.7 
31 80.2 84.8 80.3 
32 98.1 105.8 98.3 
33 86.6 96.7 91.6 
35 98.5 103.4 103.4 
36 95.4 100.3 98.2 
37 105.8 111.7 104.3 
39 84.2 100.1 82.6 
40 111.2 109.2 106.8 
41 86.6 90.2 85.3 
42 86.1 98.6 85.6 
43 91.1 99.1 90 
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Appendix A-4: Raw Data for RRI (ms) during baseline, exercise and recovery 
 
Normal 
Subject Baseline Exercise Recovery
1 610 511 612 
2 505 467 504 
3 649 582 648 
4 549 557 548 
5 652 597 626 
6 577 515 572 
7 592 569 584 
8 590 504 595 
9 605 - 613 
10 578 550 558 
11 615 590 609 
12 532 533 544 
13 742 714 735 
14 598 584 620 
 
Overweight 
Subject Baseline Exercise Recovery
15 683 616 672 
16 590 507 611 
17 525 504 518 
18 528 521 537 
19 714 713 683 
20 527 490 529 
21 653 568 632 
22 570 529 566 
23 712 650 731 
24 641 603 648 
25 579 570 587 
26 608 627 642 
27 712 599 714 
38 778 738 740 
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Obese 
Subject Baseline Exercise Recovery
28 633 539 610 
29 753 647 747 
30 653 557 619 
31 762 724 763 
32 614 570 613 
33 696 626 663 
35 614 584 585 
36 635 602 620 
37 570 541 580 
39 720 606 738 
40 540 551 563 
41 703 670 713 
42 701 611 704 
43 662 609 671 
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Appendix A-5: Raw Data for RRISD (ms) during baseline, exercise and recovery 
 
Normal 
Subject Baseline Exercise Recovery
1 34 32 42 
2 23 18 22 
3 28 38 35 
4 23 37 25 
5 87 38 64 
6 29 36 32 
7 22 28 34 
8 41 28 55 
9 36 - 43 
10 19 25 23 
11 40 39 50 
12 26 32 36 
13 117 123 113 
14 50 39 69 
 
Overweight 
Subject Baseline Exercise Recovery
15 54 52 54 
16 38 40 52 
17 29 34 29 
18 18 23 19 
19 158 155 143 
20 21 20 29 
21 107 82 98 
22 19 27 30 
23 47 61 83 
24 61 55 46 
25 55 51 58 
26 61 85 89 
27 164 43 148 
38 58 100 101 
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Obese 
Subject Baseline Exercise Recovery
28 89 67 92 
29 87 42 93 
30 108 46 90 
31 101 111 109 
32 37 41 42 
33 52 60 76 
35 61 53 51 
36 63 49 81 
37 42 46 54 
39 78 55 101 
40 24 32 22 
41 72 53 82 
42 54 36 52 
43 46 45 56 
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Appendix A-6: Raw Data for LF (ms²) during baseline, exercise and recovery 
 
Normal 
Subject Baseline Exercise Recovery
1 309 163 260 
2 171 79 253 
3 142 310 321 
4 187 259 179 
5 734 331 1137 
6 181 197 349 
7 72 364 260 
8 425 183 1219 
9 385 - 446 
10 131 33 170 
11 687 462 415 
12 163 292 414 
13 1041 1271 1552 
14 670 268 1119 
 
Overweight 
Subject Baseline Exercise Recovery
15 610 395 624 
16 269 875 836 
17 131 130 177 
18 166 164 148 
19 491 2673 705 
20 105 191 215 
21 1703 1170 1619 
22 167 80 187 
23 450 721 1141 
24 1049 911 568 
25 695 984 1178 
26 383 2472 942 
27 3294 161 2946 
38 615 2330 4675 
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Obese 
Subject Baseline Exercise Recovery
28 2114 170 7547 
29 2050 322 2066 
30 1332 336 1052 
31 902 1215 2386 
32 365 540 419 
33 531 1479 1243 
35 562 550 454 
36 861 702 1772 
37 637 1073 472 
39 1313 1136 2268 
40 217 174 164 
41 918 1356 2115 
42 1097 449 616 
43 555 1011 759 
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Appendix A-7: Raw Data for HF (ms²) during baseline, exercise and recovery 
 
Normal 
Subject Baseline Exercise Recovery
1 315 89 462 
2 50 32 56 
3 72 98 98 
4 81 147 91 
5 1341 150 1136 
6 150 205 185 
7 26 86 87 
8 249 37 1112 
9 38 - 61 
10 47 61 42 
11 412 328 423 
12 50 81 52 
13 3812 5166 4720 
14 864 532 805 
 
Overweight 
Subject Baseline Exercise Recovery
15 446 249 585 
16 127 149 110 
17 328 138 128 
18 33 61 33 
19 7229 6727 8870 
20 166 39 102 
21 4913 1834 2423 
22 43 27 61 
23 322 131 1678 
24 807 377 436 
25 399 431 796 
26 830 2037 2954 
27 13318 168 9048 
38 1808 2820 2682 
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Obese 
Subject Baseline Exercise Recovery
28 4705 112 4223 
29 2712 301 3248 
30 3639 1024 2480 
31 2244 4573 3478 
32 280 145 254 
33 736 834 630 
35 1262 1656 326 
36 1133 940 2325 
37 457 818 346 
39 2324 514 6134 
40 75 56 68 
41 1399 790 2317 
42 892 201 918 
43 533 272 929 
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Appendix A-8: Raw Data for LF/HF (ms²) during baseline, exercise and recovery 
 
Normal 
Subject Baseline Exercise Recovery
1 98.3 183.2 56.4 
2 345.6 247.4 455.8 
3 195.5 315.5 326.5 
4 231.9 176.6 197.7 
5 54.7 220.3 100.1 
6 120.2 96.4 188.8 
7 278.3 424.3 299.4 
8 170.4 501.4 109.7 
9 1008.6 - 735.9 
10 277.3 53.8 403.8 
11 166.8 140.9 97.9 
12 323.2 362.4 796.3 
13 27.3 24.6 32.9 
14 77.5 50.4 139.1 
 
Overweight 
Subject Baseline Exercise Recovery
15 136.7 158.8 106.7 
16 211.5 587.6 759.8 
17 40 93.9 138.4 
18 499.9 268.8 447.5 
19 6.8 39.7 7.9 
20 63.1 492.5 211.1 
21 34.7 63.8 66.8 
22 392.3 295.7 307.1 
23 139.7 548.2 68 
24 130.1 241.4 130.1 
25 174.2 228.4 147.9 
26 46.2 121.3 31.9 
27 24.7 95.8 32.6 
38 34 82.6 174.3 
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Obese 
Subject Baseline Exercise Recovery
28 44.9 151.9 178.7 
29 75.6 107 63.6 
30 36.6 32.9 42.4 
31 40.2 26.6 68.6 
32 130.6 371.9 165.2 
33 72.2 177.4 197.2 
35 44.6 33.2 139.1 
36 76 74.7 76.2 
37 139.4 131.2 136.4 
39 56.5 221 37 
40 289.8 307.4 239.3 
41 65.6 171.6 91.3 
42 123 223 67.1 
43 104.2 372.2 81.7 
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Appendix A-9: Raw Data for nLF (nu) during baseline, exercise and recovery 
 
Normal 
Subject Baseline Exercise Recovery
1 0.482 0.585 0.35 
2 0.716 0.661 0.761 
3 0.6 0.737 0.715 
4 0.585 0.612 0.6 
5 0.211 0.647 0.424 
6 0.412 0.461 0.584 
7 0.599 0.725 0.641 
8 0.599 0.806 0.517 
9 0.886 - 0.856 
10 0.702 0.316 0.782 
11 0.607 0.525 0.463 
12 0.757 0.777 0.876 
13 0.168 0.16 0.189 
14 0.422 0.32 0.563 
 
Overweight 
Subject Baseline Exercise Recovery
15 0.539 0.58 0.474 
16 0.647 0.852 0.839 
17 0.238 0.253 0.5 
18 0.789 0.718 0.783 
19 0.041 0.218 0.061 
20 0.37 0.801 0.652 
21 0.243 0.368 0.336 
22 0.741 0.733 0.634 
23 0.534 0.765 0.356 
24 0.527 0.675 0.493 
25 0.477 0.647 0.54 
26 0.199 0.491 0.208 
27 0.181 0.476 0.197 
38 0.24 0.429 0.623 
 
 
 
 40
Obese 
Subject Baseline Exercise Recovery
28 0.298 0.557 0.626 
29 0.405 0.35 0.38 
30 0.215 0.232 0.257 
31 0.181 0.178 0.345 
32 0.537 0.782 0.517 
33 0.35 0.587 0.636 
35 0.287 0.233 0.553 
36 0.407 0.389 0.416 
37 0.537 0.558 0.522 
39 0.338 0.67 0.259 
40 0.722 0.724 0.676 
41 0.381 0.599 0.466 
42 0.539 0.654 0.395 
43 0.481 0.751 0.437 
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Appendix A-10: Raw Data for nHF (nu) during baseline, exercise and recovery 
 
Normal 
Subject Baseline Exercise Recovery
1 0.49 0.319 0.62 
2 0.207 0.267 0.167 
3 0.307 0.234 0.219 
4 0.252 0.347 0.304 
5 0.386 0.294 0.423 
6 0.343 0.479 0.309 
7 0.215 0.171 0.214 
8 0.352 0.161 0.471 
9 0.088 - 0.116 
10 0.253 0.588 0.194 
11 0.364 0.372 0.473 
12 0.234 0.214 0.11 
13 0.616 0.65 0.575 
14 0.544 0.634 0.405 
 
Overweight 
Subject Baseline Exercise Recovery
15 0.394 0.365 0.444 
16 0.306 0.145 0.11 
17 0.595 0.27 0.362 
18 0.158 0.267 0.175 
19 0.604 0.549 0.762 
20 0.587 0.163 0.309 
21 0.701 0.577 0.503 
22 0.189 0.248 0.206 
23 0.382 0.139 0.524 
24 0.405 0.279 0.379 
25 0.274 0.283 0.365 
26 0.431 0.404 0.653 
27 0.732 0.496 0.604 
38 0.705 0.519 0.357 
 
 
 
 42
Obese 
Subject Baseline Exercise Recovery
28 0.664 0.366 0.35 
29 0.535 0.327 0.598 
30 0.586 0.706 0.607 
31 0.451 0.669 0.504 
32 0.411 0.21 0.313 
33 0.485 0.331 0.323 
35 0.645 0.702 0.398 
36 0.535 0.521 0.546 
37 0.385 0.425 0.383 
39 0.599 0.303 0.702 
40 0.249 0.236 0.282 
41 0.58 0.349 0.51 
42 0.438 0.293 0.589 
43 0.462 0.202 0.534 
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Appendix A-11: Raw Data for Respiration (breaths/min) during baseline, exercise and 
recovery 
 
Normal 
Subject Baseline Exercise Recovery
1 18 27 21 
2 26 24 25 
3 23 26 23 
4 23 27 25 
5 29 35 29 
6 26 29 27 
7 27 28 26 
8 28 33 24 
9 25 *** 25 
10 19 23 21 
11 20 22 21 
12 36 35 30 
13 28 32 26 
14 32 29 23 
 
Overweight 
Subject Baseline Exercise Recovery
1 29 43 28 
2 29 31 26 
3 24 24 24 
4 28 26 27 
5 25 27 24 
6 23 26 23 
7 18 20 20 
8 30 39 28 
9 23 20 22 
10 22 33 26 
11 25 29 25 
12 24 25 21 
13 19 33 21 
14 23 20 19 
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Obese 
Subject Baseline Exercise Recovery
28 22 30 21 
29 19 28 17 
30 32 41 31 
31 24 30 24 
32 31 32 27 
33 26 27 26 
35 23 23 24 
36 28 29 26 
37 26 26 22 
39 24 20 18 
40 22 26 23 
41 21 28 23 
42 24 28 21 
43 22 27 19 
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Appendix B-1: Means for normal, overweight and obese children - demographics 
 
Variable Group N Mean 
HT Normal 14 103 ± 1 
 Overweight 14 106 ± 1 
 Obese 14 111 ± 3 
WT Normal 14 17 ± 0 
 Overweight 14 20 ± 1 
 Obese 14 24 ± 1 
BMI Normal 14 16 ± 0 
 Overweight 14 17 ± 0 
 Obese 14 19 ± 0 
SAP Normal 14 88 ± 3 
 Overweight 14 87 ± 3 
 Obese 14 92 ± 2 
DAP Normal 14 59 ± 1 
 Overweight 14 59 ± 1 
 Obese 14 59 ± 1 
MAP Normal 14 69 ± 2 
 Overweight 14 68 ± 2 
 Obese 14 70 ± 2 
MVC Normal 14 2 ± 0 
 Overweight 14 2 ± 0 
 Obese 14 2 ± 0 
 
HT, height (cm); WT, weight (kg); BMI, body mass index (kg/m²); 
SAP, systolic arterial blood pressure (mmHg); DAP, diastolic 
arterial blood pressure (mmHg); MAP, mean arterial blood 
pressure (mmHg); MVC, maximal voluntary contraction (p.s.i.). 
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Appendix B-2: Means for normal, overweight and obese children – HRV variables 
 
Variable Group N Baseline Exercise Recovery 
HR Normal 13 102 ± 3 109 ± 3 102 ± 3 
 Overweight 14 98 ± 3 104 ± 3 98 ± 3 
 Obese 14 93 ± 2 102 ± 2 93 ± 2 
RRI Normal 13 599 ± 17 559 ± 17 597 ± 16 
 Overweight 14 630 ± 22 588 ± 21 629 ± 20 
 Obese 14 661 ± 17 603 ± 14 656 ± 18 
RRISD Normal 13 41 ± 8 39 ± 7 46 ± 7 
 Overweight 14 64 ± 13 59 ± 10 70 ± 11 
 Obese 14 65 ± 7 53 ± 5 72 ± 7 
LF Normal 13 378 ± 85 324 ± 85 588 ± 133 
 Overweight 14 723 ± 229 947 ± 244 1140 ± 336 
 Obese 14 961 ± 154 751 ± 120 1667 ± 497 
HF Normal 13 575 ± 290 539 ± 387 713 ± 352 
 Overweight 14 2198 ± 1025 1085 ± 496 2136 ± 820 
 Obese 14 1599 ± 364 874 ± 309 1977 ± 484 
LF_HF Normal 13 182 ± 29 215 ± 42 246 ± 59 
 Overweight 14 138 ± 39 237 ± 49 188 ± 54 
 Obese 14 93 ± 18 172 ± 31 113 ± 17 
nLF Normal 13 0.5 ± 0.1 0.6 ± 0.1 0.6 ± 0.1 
 Overweight 14 0.4 ± 0.1 0.6 ± 0.1 0.5 ± 0.1 
 Obese 14 0.4 ± 0.0 0.5 ± 0.1 0.5 ± 0.0 
nHF Normal 13 0.4 ± 0.0 0.4 ± 0.1 0.3 ± 0.0 
 Overweight 14 0.5 ± 0.1 0.3 ± 0.0 0.4 ± 0.1 
 Obese 14 0.5 ± 0.0 0.4 ± 0.1 0.5 ± 0.0 
Resp Normal 13 26 ± 1 28 ± 1 25 ± 1 
 Overweight 14 25 ± 1 28 ± 2 24 ± 1 
 Obese 14 24 ± 1 28 ± 2 23 ± 1 
 
HR, heart rate (bpm); RRI, RR intervals (ms); RRISD, RR interval standard deviation  
(ms); LF, low frequency (ms²); HF, high frequency (ms²); LF/HF, low to high frequency 
 ratio (ms²); nLF, normalized low frequency (nu); nHF, normalized high frequency (nu);  
Resp, Respiration breaths per minute.  Values reported as mean ± standard error. 
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Appendix C-1: Repeated Measures ANOVA 
 
HR        
       
Within 
Subjects Effect 
Mauchly's  
W 
Approx.  
Chi-Sqaure df Sig. 
Greenhouse 
- Geisser  
Condition 0.454 29.199 2 0.000 0.647  
       
       
Source   
Type III  Sum 
of Squares df 
 Mean 
Square F Sig. 
Condition 
Greenhouse-
Geisser 1465.373 1.294 1132.571 58.861 0.000 
       
Condition * 
Group 
Greenhouse-
Geisser 12.06 2.588 4.661 0.242 0.839 
 
 
 
 
 
RRI       
       
Within 
Subjects Effect 
Mauchly's  
W 
Approx.  
Chi-Sqaure df Sig. 
Greenhouse 
- Geisser  
Condition 0.532 23.363 2 0.000 0.681  
       
       
Source   
Type III  Sum 
of Squares df 
 Mean 
Square F Sig. 
Condition 
Greenhouse-
Geisser 56188.650 1.362 41247.322 57.910 0.000 
       
Condition * 
Group 
Greenhouse-
Geisser 1701.686 2.724 624.592 0.877 0.451 
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RRISD       
       
Within 
Subjects Effect 
Mauchly's  
W 
Approx.  
Chi-Sqaure df Sig. 
Greenhouse 
- Geisser  
Condition 0.600 18.872 2 0.000 0.715  
       
       
Source   
Type III  Sum 
of Squares df 
 Mean 
Square F Sig. 
Condition 
Greenhouse-
Geisser 3018.054 1.429 2111.943 6.583 0.007 
       
Condition * 
Group 
Greenhouse-
Geisser 647.545 2.858 226.566 0.706 0.546 
 
 
 
 
 
LF       
       
Within 
Subjects Effect 
Mauchly's  
W 
Approx.  
Chi-Sqaure df Sig. 
Greenhouse 
- Geisser  
Condition 0.773 9.509 2 0.009 0.815  
       
       
Source   
Type III  Sum 
of Squares df 
 Mean 
Square F Sig. 
Condition Huynh-Feldt 5555901.377 1.783 3115909.418 4.225 0.022 
       
Condition * 
Group Huynh-Feldt 2475830.308 3.566 694258.452 0.941 0.438 
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HF       
       
Within 
Subjects Effect 
Mauchly's  
W 
Approx.  
Chi-Sqaure df Sig. 
Greenhouse 
- Geisser  
Condition 0.533 23.265 2 0.000 0.682  
       
       
Source   
Type III  Sum 
of Squares df 
 Mean 
Square F Sig. 
Condition 
Greenhouse-
Geisser 1.385E+07 1.364 1.016E+07 4.073 0.037 
       
Condition * 
Group 
Greenhouse-
Geisser 5535858.337 2.727 2029937.26 0.814 0.482 
 
 
 
 
 
LF/HF       
      
Within 
Subjects Effect 
Mauchly's  
W 
Approx.  
Chi-Sqaure df Sig. 
Greenhouse 
- Geisser  
Condition 0.885 4.502 2 0.105 0.897  
       
       
Source   
Type III  Sum 
of Squares df 
 Mean 
Square F Sig. 
Condition 
Sphericity 
Assumed 103625.585 2 51812.793 4.677 0.012 
       
Condition * 
Group 
Sphericity 
Assumed 36360.964 4 9090.241 0.821 0.516 
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nLF       
       
Within 
Subjects Effect 
Mauchly's 
 W 
Approx. 
 Chi-Sqaure df Sig. 
Greenhouse 
- Geisser  
Condition 0.842 6.368 2 0.041 0.863  
       
       
Source   
Type III  Sum 
of Squares df 
 Mean 
Square F Sig. 
Condition Huynh-Feldt 0.219 1.897 0.115 7.945 0.001 
       
Condition * 
Group Huynh-Feldt 0.060 3.794 0.016 1.097 0.363 
 
 
 
 
 
nHF       
       
Within 
Subjects Effect 
Mauchly's  
W 
Approx.  
Chi-Sqaure df Sig. 
Greenhouse 
- Geisser  
Condition 0.888 4.387 2 0.112 0.899  
       
       
Source   
Type III  Sum 
of Squares df 
 Mean 
Square F Sig. 
Condition 
Sphericity 
Assumed 0.103 2 0.052 4.036 0.022 
       
Condition * 
Group 
Sphericity 
Assumed 0.078 4 0.019 1.515 0.206 
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Respiration       
       
Within 
Subjects Effect 
Mauchly's  
W 
Approx.  
Chi-Sqaure df Sig. 
Greenhouse 
- Geisser  
Condition 0.665 15.080 2 0.001 0.749  
       
       
Source   
Type III  Sum 
of Squares df 
 Mean 
Square F Sig. 
Condition 
Greenhouse-
Geisser 365.599 1.498 243.987 24.503 0.000 
       
Condition * 
Group 
Greenhouse-
Geisser 10.942 2.997 3.651 0.367 0.777 
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Appendix C-2: Post Hoc analysis for demographics 
PAIRED T-TESTS      
95% Confidence Interval 
  Mean Lower Upper t Df 
Sig. (2-
tailed) 
HT       
N vs. OV -3.109 -7.139 0.921 -1.667 13 0.119 
N vs. OB -7.261 -13.145 -1.377 -2.666 13 0.019 
OV vs. OB -4.151 -9.569 1.267 -1.655 13 0.122 
WT       
N vs. OV -2.863 -4.336 -1.389 -4.198 13 0.001 
N vs. OB -7.151 -10.346 -3.956 -4.836 13 0.000 
OV vs. OB -4.289 -7.216 -1.362 -3.166 13 0.007 
BMI       
N vs. OV -1.609 -2.182 -1.036 -6.066 13 0.000 
N vs. OB -3.646 -4.717 -2.575 -7.353 13 0.000 
OV vs. OB -2.036 -3.028 -1.045 -4.439 13 0.001 
SAP       
N vs. OV 1.650 -8.503 11.803 0.351 13 0.731 
N vs. OB -3.740 -11.484 4.003 -1.043 13 0.316 
OV vs. OB -5.390 -15.236 4.456 -1.183 13 0.258 
DAP       
N vs. OV 0.371 -4.465 5.208 0.166 13 0.871 
N vs. OB 0.271 -4.234 4.777 0.130 13 0.898 
OV vs. OB -0.100 -5.039 4.839 -0.044 13 0.966 
MAP       
N vs. OV 0.798 -4.555 6.151 0.322 13 0.753 
N vs. OB -1.066 -5.982 3.851 -0.468 13 0.647 
OV vs. OB -1.863 -7.529 3.792 -0.712 13 0.489 
MVC       
N vs. OV -0.214 -0.534 0.105 -1.450 13 0.171 
N vs. OB -0.450 -0.909 0.009 -2.116 13 0.054 
OV vs. OB -0.236 -0.577 0.105 -1.494 13 0.159 
 
HT, height (cm); WT, weight (kg); BMI, body mass index (kg/m²); SAP, systolic 
 arterial blood pressure (mmHg); DAP, diastolic arterial blood pressure (mmHg);  
MAP, mean arterial blood pressure (mmHg); MVC, maximal voluntary  
contraction (p.s.i.); N, normal weight; OV, overweight; OB (obese). 
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Appendix C-3: Post Hoc analyses for HRV variables 
PAIRED T-TESTS     
95% Confidence Interval 
  Mean Lower Upper T df 
Sig. (2-
tailed) 
HR       
  B vs. E -7.529 -1.154 0.402 -0.977 40 0.000 
  B vs. R -0.376 -1.154 0.402 -0.977 41 0.334 
RRI       
  B vs. E 46.829 35.578 58.081 8.412 40 0.000 
  B vs. R 2.452 -2.864 7.769 0.932 41 0.357 
RRISD       
  B vs. E 6.488 -1.797 14.773 1.5834 40 0.121 
  B vs. R -5.801 -10.071 -1.548 -2.753 41 0.009 
LF       
  B vs. E 12.512 -275.386 300.410 0.088 40 0.930 
  B vs. R -440.67 -775.705 -105.629 -2.656 41 0.011 
HF       
  B vs. E 638.854 -94.472 1372.179 1.761 40 0.086 
  B vs. R -148.690 -514.623 217.242 -0.821 41 0.417 
LF/HF       
  B vs. E -71.161 -116.633 -25.689 -3.163 40 0.003 
  B vs. R -36.798 -78.403 4.807 -1.786 41 0.081 
nLF       
  B vs. E -0.105 -0.155 -0.054 -4.186 40 0.000 
  B vs. R -0.055 -0.098 -0.012 -2.597 41 0.013 
nHF       
  B vs. E 0.073 0.022 0.123 2.907 40 0.006 
  B vs. R 0.027 -0.015 0.069 1.294 41 0.203 
Resp       
  B vs. E -3.057 -4.495 -1.619 -4.297 40 0.000 
  B vs. R 1.000 0.211 1.789 2.558 41 0.014 
 
HR, heart rate (bpm); RRI, RR intervals (ms); RRISD, RR interval standard  
deviation (ms); LF, low frequency (ms²); HF, high frequency (ms²); LF/HF, 
 low to high frequency ratio (ms²); nLF, normalized low frequency (nu); nHF,  
normalized high frequency (nu); Resp, Respiration breaths per minute; 
 N (normal weight); OV (overweight); OB (obese). 
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Appendix C-4:  Statistics for BMI   
 
NONPARAMETRIC CORRELATIONS 
Spearman's rho 
   
  n r Sig. 
HR 42 -0.257 0.100 
RRI 42 0.264 0.091 
RRISD 42 0.375 0.014 
LF 42 0.427 0.005 
HF 42 0.432 0.004 
LF/HF 42 -0.322 0.038 
nLF 42 -0.280 0.072 
nHF 42 0.406 0.008 
Resp 42 -0.140 0.376 
SAP 42 0.118 0.455 
DAP 42 0.070 0.661 
MAP 42 0.068 0.668 
HT 42 0.367 0.017 
WT 42 0.753 0.000 
MVC 42 0.242 0.123 
 
HR, heart rate (bpm); RRI, RR intervals (ms); RRISD, RR interval standard  
deviation (ms); LF, low frequency (ms²); HF, high frequency (ms²); LF/HF,  
low to high frequency ratio (ms²); nLF, normalized low frequency (nu); nHF,  
normalized high frequency (nu); Resp, Respiration breaths per minute; SAP,  
systolic arterial blood pressure (mmHg); DAP, diastolic arterial blood pressure 
(mmHg); MAP, mean arterial blood pressure (mmHg); HT, height (cm);  
WT, weight (kg); BMI, body mass index (kg/m²);  MVC, maximal  
voluntary contraction (p.s.i.). 
 
 
 
 
